U.S., Aug. 20 -- An application to own the trademark for 'DAWNZERA' has been filed on Dec. 19, 2024.
Owner(s):
Ionis Pharmaceuticals, Inc.; 2855 Gazelle Court, , CALIFORNIA
Goods and/or Services:
For: Pharmaceutical preparations and substances for the treatment of edema, namely hereditary angioedema; pharmaceutical preparations for the treatment of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)
https://eog-tmng.uspto.gov/#/issueDate=2025-08-19&serialNumber=98913102
Disclaimer:...